Zobrazeno 1 - 10
of 51
pro vyhledávání: '"Clarie B Hollenbeck"'
Publikováno v:
Proceedings of the Society for Experimental Biology and Medicine. 224:166-171
Publikováno v:
The Journal of Clinical Endocrinology & Metabolism. 87:118-121
Postmenopausal women are at an increased risk of developing coronary artery disease (CAD). This increase is due primarily to elevated cholesterol concentrations accompanying the loss of endogenous estrogen secretion. Recently, the consumption of soy
Autor:
J. Foote, C. Clinkingbeard, Clarie B Hollenbeck, Jørgen Jeppesen, Gerald M. Reaven, P. Maheux, Y-D. Ida Chen, D. Pei
Publikováno v:
American Journal of Hypertension. 8:461-466
Patients with high blood pressure tend to be insulin resistant, glucose intolerant, hyperinsulinemic, and dyslipidemic. Since these metabolic defects are accentuated by obesity, we thought it important to compare the effects of 3 months' treatment wi
Autor:
Gerald M. Reaven, Ann M. Coulston, Clarie B Hollenbeck, Jørgen Jeppesen, Y.-D. Ida Chen, Claire N Jones, M. Y. Zhou
Publikováno v:
Arteriosclerosis, Thrombosis, and Vascular Biology. 15:320-324
Abstract We examined the relation between insulin resistance, plasma glucose and insulin responses to meals, lipoprotein lipase (LPL) activity, and postprandial lipemia in a population of 37 healthy nondiabetic individuals. Plasma glucose and insulin
Autor:
D. Ostrega, Kenneth S. Polonsky, Wayne H.-H. Sheu, Gerald M. Reaven, Clarie B Hollenbeck, Y-D. Ida Chen
Publikováno v:
The Journal of Clinical Endocrinology & Metabolism. 76:44-48
Conventional immunoassays to quantify insulin concentration do not differentiate between insulin and proinsulin. Thus, previous conclusions as to the relationship between the development of hyperglycemia in patients with noninsulin-dependent diabetes
Autor:
Clarie B Hollenbeck, R. Skowronski, P. Johnston, Gerald M. Reaven, I D Goldfine, J C Zhang, Yi Chen
Publikováno v:
The Journal of Clinical Endocrinology & Metabolism. 74:1020-1026
The effect of metformin treatment was studied in 13 patients with noninsulin-dependent diabetes mellitus (NIDDM), whose fasting plasma glucose concentration was greater than 10 mmol/L with maximal sulfonylurea doses. Patients were studied before and
Publikováno v:
Diabetic Medicine. 8:32-39
Nineteen patients with Type 2 diabetes were treated with glipizide for 2.5–6 months, and measurements made of metabolic variables before and after glipizide treatment. For purposes of analysis, the glipizide associated decrease in fasting plasma gl
Autor:
Clarie B Hollenbeck, Ann M. Coulston
Publikováno v:
Canadian Journal of Physiology and Pharmacology. 69:100-107
A classification of carbohydrate-containing foods based on their glycemic response to 50-g carbohydrate portions has recently been developed. The relative glycemic potency of many of these carbohydrate-containing foods have been compared, and these d
Autor:
Wayne H.-H. Sheu, Y.-D. Ida Chen, Gerald M. Reaven, Johnathan B. Jaspan, Min-Shung Wu, Clarie B Hollenbeck
Publikováno v:
The Journal of Clinical Endocrinology & Metabolism. 70:1354-1360
This study was carried out to determine whether hepatic glucose production (HGP) could be suppressed in normal subjects by infusing different amounts of glucose, in the absence of significant changes in steady state plasma glucose (SSPG) or insulin (
Publikováno v:
The Journal of Clinical Endocrinology & Metabolism. 70:410-416
To evaluate the effect of glucagon on regulation of plasma FFA concentration, continuous iv infusions of either somatostatin (S) or somatostatin (S) plus glucagon (G) were administered to 18 individuals with normal glucose tolerance. In 9 of these in